Latest Articles
S01 E05 - Dispelling the myths of a 'lazy girl's diagnosis' | (MIS)Treated - TVO
S01 E05 - Dispelling the myths of a 'lazy girl's diagnosis' | (MIS)Treated TVO
Published: Oct. 28, 2025, 1 p.m.
Pearsanta initiates study of blood test for early endometriosis detection - Medical Device Network
Pearsanta initiates study of blood test for early endometriosis detection Medical Device Network
Published: Oct. 28, 2025, 11:10 a.m.
Pearsanta initiates study of blood test for early endometriosis detection - Yahoo
Pearsanta initiates study of blood test for early endometriosis detection Yahoo
Published: Oct. 28, 2025, 10:05 a.m.
The pain women keep being told to ignore: Why pelvic pain is not always endometriosis - India TV News
The pain women keep being told to ignore: Why pelvic pain is not always endometriosis India TV News
Published: Oct. 28, 2025, 9:50 a.m.
Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up - Nature
Risk factors for postoperative recurrence of deep infiltrating endometriosis during a 6- to 12-year follow-up Nature
Published: Oct. 28, 2025, 8:59 a.m.
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer - BioSpace
CORRECTING and REPLACING Faeth Therapeutics' $92 Million Total Funding Powers PIKTOR Phase 2 Following 80% Response Rate in Endometrial Cancer BioSpace
Published: Oct. 28, 2025, 5:03 a.m.
Bayer’s New Study on Mirena: A Potential Game-Changer for Endometrial Hyperplasia Treatment - TipRanks
Bayer’s New Study on Mirena: A Potential Game-Changer for Endometrial Hyperplasia Treatment TipRanks
Published: Oct. 27, 2025, 11:58 p.m.
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study - TipRanks
Iovance Biotherapeutics Advances in Endometrial Cancer Treatment with Lifileucel Study TipRanks
Published: Oct. 27, 2025, 10:21 p.m.
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic - citybuzz -
Aditxt Subsidiary Pearsanta Launches Clinical Study for Blood-Based Endometriosis Diagnostic citybuzz -
Published: Oct. 27, 2025, 9:33 p.m.
Acrivon Therapeutics Advances Phase 2 Study for Endometrial Cancer Treatment - TipRanks
Acrivon Therapeutics Advances Phase 2 Study for Endometrial Cancer Treatment TipRanks
Published: Oct. 27, 2025, 9:13 p.m.
Link copied to clipboard!